Strategies for India to Reduce Its API Dependence on China

Janifha Evangeline, Assistant Editor, India Pharma Outlook

India's status as the "pharmacy of the world" is based on its ability to create drug details and nonexclusive medications. Be that as it may, this standing lays on a tricky establishment, with roughly 70% of its Dynamic Drug Fixings (APIs) obtained..

Business Impact of USFDA Approvals on Indian Pharma Companies

Rejith P R, Correspondent, India Pharma Outlook

Alembic Pharmaceuticals has received final approval from the US FDA for its generic Diltiazem Hydrochloride extended-release capsules, which are indicated for the treatment of hypertension. The capsule's anticipated market size was USD 105.3...

How Innovative Drug Formulations are Enhancing Treatment Outcomes

Rejith P R, Correspondent, India Pharma Outlook

Lindy Biosciences, a protein therapeutic formulations firm, has announced a partnership with Novartis Pharmaceuticals to focus more on evolving drugs from Novartis to subcutaneous injections by using their micro classification suspension...

Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies

Janifha Evangeline, Assistant Editor, India Pharma Outlook

Owing to the direct impact of its products on public health & safety, the pharma sector operates within a highly regulated environment

Pharma Pollution: The Hidden Crisis of Pharmaceutical Contamination

Janifha Evangeline, Assistant Editor, India Pharma Outlook

A few months ago, lawmakers in Europe signed off on an update to the urban waste water treatment directive

How Partnerships are Shaping Pharma R&D

Janifha Evangeline, Assistant Editor, India Pharma Outlook

Isomorphic Labs, on the 7th of January this year announced that it has entered into strategic partnerships with Eli Lilly

© 2024 India Pharma Outlook. All Rights Reserved.